Fundraising Fox

Safar Partners2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Imago Rehabimagorehab.comJul 2024

Imago Rehab provides at-home rehabilitation for people recovering from neurological or cardiovascular conditions, using one-on-one therapy delivered via telerehabilitation combined with robotic devices, gamification, and an integrated care team.

Digital HealthHealthtechMedical DevicesRoboticsLowell, US

Kristin Nuckols(Executive Officer)inConor James Walsh(Director)Gene Tacy(Executive Officer)Chris Dugan(Executive Officer, Director)Tom Hunter(Executive Officer)

Board seatArunas A. Chesonis· per SEC Form D

Co-investorsBantam GroupBeacon AngelsLaunchpad Venture GroupWalnut Venture Associates

Cerberus Venturescerberus.comDec 2024 · $18M

Cerberus is an alternative investment advisor managing approximately $70 billion across credit, private equity, and real estate platforms, including direct lending, corporate credit, non-performing loans, residential and commercial real estate, and early-stage venture investing.

Fintech

Co-investorsAHL Venture PartnersBooz Allen VenturesClean Energy VenturesBallistic VenturesForgePoint CapitalIAG Capital Partners+1 more

Health Care Originalshealthcareoriginals.comSep 2024

HealthtechRochester, US

SHARON SAMJITSINGH(Executive Officer, Director)JARED DWARIKA(Executive Officer, Director)PARINAZ MOTAMEDY(Director)

BoardERIC ALLYN(Director)BRADFORD BERK(Director)KEITH WILSON(Director)

Co-investorsChloe CapitalD3VCCranberry CapitalSimon School Venture Fund

Pirouette Pharmapirouettepharma.comin𝕏May 2024

Pirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications.

Advanced ManufacturingBiotechHealthtechMedical DevicesBoston, US

Conor Cullinane(Founder)inMatthew Kane(Founder)inElijah Kapas(Founder)in

BoardPARINAZ MOTAMEDY(Director)inJOSEPH NEMMERS(Director)

Co-investorsY CombinatorGaingelsFoundersHelium-3 Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.